Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Roesch

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Pharmaceutics|March 29, 2023
[<sup>111</sup>In]In/[<sup>177</sup>Lu]Lu-AAZTA<sup>5</sup>-LM4 SST<sub>2</sub>R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient ResultsBerthold A Nock, Panagiotis Kanellopoulos, Euy Sung Moon, et al.
Nuklearmedizin. Nuclear Medicine|May 12, 2020
[68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor ImagingBarbara Kreppel, Florian C Gärtner, Milka Marinova, et al.
Nuclear Medicine and Biology|May 7, 2016
Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept studyValery Radchenko, Penelope Bouziotis, Theodoros Tsotakos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2023
Head-to-head comparison of [<sup>68</sup>Ga]Ga-DOTA.SA.FAPi with [<sup>18</sup>F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancersSanjana Ballal, Madhav P Yadav, Frank Roesch, et al.
Journal of Medicinal Chemistry|April 24, 2024
Druglike, <sup>18</sup>F-labeled PET Tracers Targeting Fibroblast Activation ProteinMuhammet Tanc, Nicolò Filippi, Yentl Van Rymenant, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Pharmaceutics|March 29, 2023
[<sup>111</sup>In]In/[<sup>177</sup>Lu]Lu-AAZTA<sup>5</sup>-LM4 SST<sub>2</sub>R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient ResultsBerthold A Nock, Panagiotis Kanellopoulos, Euy Sung Moon, et al.
Nuklearmedizin. Nuclear Medicine|May 12, 2020
[68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor ImagingBarbara Kreppel, Florian C Gärtner, Milka Marinova, et al.
Nuclear Medicine and Biology|May 7, 2016
Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept studyValery Radchenko, Penelope Bouziotis, Theodoros Tsotakos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2023
Head-to-head comparison of [<sup>68</sup>Ga]Ga-DOTA.SA.FAPi with [<sup>18</sup>F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancersSanjana Ballal, Madhav P Yadav, Frank Roesch, et al.
Journal of Medicinal Chemistry|April 24, 2024
Druglike, <sup>18</sup>F-labeled PET Tracers Targeting Fibroblast Activation ProteinMuhammet Tanc, Nicolò Filippi, Yentl Van Rymenant, et al.
Pageof 7